Psychological risk factors and the metabolic syndrome in patients with coronary heart disease: findings from the Heart and Soul Study.

Beth E Cohen, Praveen Panguluri, Beeya Na, Mary A Whooley
Author Information
  1. Beth E Cohen: General Internal Medicine, VA Medical Center, San Francisco, CA, United States; Department of Medicine, University of California, San Francisco, CA, USA. Beth.Cohen@ucsf.edu

Abstract

Psychological factors, such as depression and anxiety, are independently associated with an increased risk of both diabetes mellitus and cardiovascular disease, but the reasons for these associations are unknown. We sought to determine whether psychological factors were associated with a greater prevalence of the metabolic syndrome in patients with coronary heart disease, and the extent to which such an association may be explained by socioeconomic status, health behaviors, and biological mediators. We conducted a cross-sectional study of 1024 outpatients with stable coronary heart disease. Psychological factors, including depressive and anxiety symptoms, hostility, anger, and optimism-pessimism, were assessed using validated standardized questionnaires. The presence or absence of the metabolic syndrome was determined using the criteria outlined by the National Cholesterol Education Program, Adult Treatment Panel III. Higher levels of depression, anger expression, hostility, and pessimism were significantly associated with increased prevalence of the metabolic syndrome. These associations were explained by differences in socioeconomic status and health behaviors. Additional adjustment for potential biological mediators had little impact. Further research is needed to determine whether addressing socioeconomic and behavioral factors in people with depression or high levels of anger or hostility could reduce the burden of the metabolic syndrome.

References

  1. Metabolism. 2002 Dec;51(12):1573-7 [PMID: 12489070]
  2. Am J Cardiol. 2005 Dec 1;96(11):1506-11 [PMID: 16310431]
  3. Diabetes Care. 2001 Apr;24(4):683-9 [PMID: 11315831]
  4. Psychosom Med. 2008 Jan;70(1):40-8 [PMID: 18158378]
  5. Acta Psychiatr Scand. 1983 Jun;67(6):361-70 [PMID: 6880820]
  6. J Gerontol B Psychol Sci Soc Sci. 2006 Sep;61(5):P295-303 [PMID: 16960233]
  7. Qual Life Res. 2007 Mar;16(2):165-77 [PMID: 17033903]
  8. Am J Med. 2008 Jan;121(1):50-7 [PMID: 18187073]
  9. Psychosom Med. 2002 May-Jun;64(3):418-35 [PMID: 12021416]
  10. Arch Gen Psychiatry. 1998 Feb;55(2):161-6 [PMID: 9477930]
  11. Obes Res. 1996 May;4(3):245-52 [PMID: 8732958]
  12. Horm Metab Res. 2006 Jul;38(7):437-41 [PMID: 16933178]
  13. Diabetes Care. 1996 Oct;19(10):1097-102 [PMID: 8886555]
  14. JAMA. 1999 Nov 10;282(18):1737-44 [PMID: 10568646]
  15. Psychosomatics. 2002 Sep-Oct;43(5):405-12 [PMID: 12297610]
  16. J Gerontol A Biol Sci Med Sci. 2007 May;62(5):563-9 [PMID: 17522363]
  17. Psychosom Med. 2004 May-Jun;66(3):316-22 [PMID: 15184689]
  18. Am J Cardiol. 2005 May 15;95(10):1175-9 [PMID: 15877989]
  19. Diabetes Care. 2005 May;28(5):1063-7 [PMID: 15855568]
  20. Am Heart J. 2005 Jul;150(1):54-78 [PMID: 16084151]
  21. Arch Gen Psychiatry. 2004 Oct;61(10):1042-9 [PMID: 15466678]
  22. WMJ. 1998 Dec;97(11):34-8 [PMID: 9894438]
  23. J Psychosom Res. 2002 Feb;52(2):69-77 [PMID: 11832252]
  24. Diabetes Care. 2007 Apr;30(4):872-7 [PMID: 17392548]
  25. Prog Neuropsychopharmacol Biol Psychiatry. 1995 Jan;19(1):11-38 [PMID: 7708925]
  26. J Pers Soc Psychol. 1989 Dec;57(6):1024-40 [PMID: 2614656]
  27. JAMA. 2003 May 21;289(19):2560-72 [PMID: 12748199]
  28. Am J Epidemiol. 2004 Jun 1;159(11):1013-8 [PMID: 15155285]
  29. Psychosom Med. 2006 Mar-Apr;68(2):213-6 [PMID: 16554385]
  30. J Hypertens. 1990 Sep;8(9):783-93 [PMID: 2172367]
  31. Am Heart J. 2008 Feb;155(2):303-9 [PMID: 18215601]
  32. J Am Coll Cardiol. 2005 Mar 1;45(5):637-51 [PMID: 15734605]
  33. Am J Cardiol. 2003 Oct 15;92(8):901-6 [PMID: 14556863]
  34. J Psychosom Res. 2002 Oct;53(4):903-6 [PMID: 12377301]
  35. J Thromb Haemost. 2005 May;3(5):897-908 [PMID: 15869583]
  36. JAMA. 2001 May 16;285(19):2486-97 [PMID: 11368702]
  37. Biol Psychiatry. 2007 Dec 1;62(11):1251-7 [PMID: 17553465]
  38. Circulation. 2006 Apr 11;113(14):1760-7 [PMID: 16567568]
  39. J Gen Intern Med. 2001 Sep;16(9):606-13 [PMID: 11556941]
  40. Metabolism. 1996 Dec;45(12):1533-8 [PMID: 8969288]
  41. Psychoneuroendocrinology. 2005 Jan;30(1):1-10 [PMID: 15358437]
  42. Arch Intern Med. 2000 Jul 10;160(13):1913-21 [PMID: 10888966]
  43. J Psychosom Res. 1997 Jan;42(1):17-41 [PMID: 9055211]
  44. JAMA. 2001 Jul 18;286(3):327-34 [PMID: 11466099]
  45. Circulation. 2002 Nov 19;106(21):2659-65 [PMID: 12438290]

Grants

  1. UL1 RR024130/NCRR NIH HHS
  2. R01 HL079235/NHLBI NIH HHS
  3. R01 HL079235-01A1/NHLBI NIH HHS
  4. KL2 RR024130/NCRR NIH HHS
  5. K23 HL094765/NHLBI NIH HHS

MeSH Term

Aged
Cohort Studies
Coronary Disease
Depression
Female
Humans
Male
Metabolic Syndrome
Middle Aged
Psychiatric Status Rating Scales
Psychological Tests
Psychology
Retrospective Studies
Risk Factors
Socioeconomic Factors
Stress, Psychological
Surveys and Questionnaires

Word Cloud

Created with Highcharts 10.0.0factorsmetabolicsyndromePsychologicaldepressionassociateddiseasecoronaryheartsocioeconomichostilityangeranxietyincreasedriskassociationsdeterminewhetherprevalencepatientsexplainedstatushealthbehaviorsbiologicalmediatorsusinglevelsindependentlydiabetesmellituscardiovascularreasonsunknownsoughtpsychologicalgreaterextentassociationmayconductedcross-sectionalstudy1024outpatientsstableincludingdepressivesymptomsoptimism-pessimismassessedvalidatedstandardizedquestionnairespresenceabsencedeterminedcriteriaoutlinedNationalCholesterolEducationProgramAdultTreatmentPanelIIIHigherexpressionpessimismsignificantlydifferencesAdditionaladjustmentpotentiallittleimpactresearchneededaddressingbehavioralpeoplehighreduceburdendisease:findingsHeartSoulStudy

Similar Articles

Cited By